ABOUT US

A wholly owned subsidiary of a global pharmaceutical supplier

OUR PRODUCTS

First to market pharmaceutical compounds; unique, therapeutically optimized combinations; value branded equivalents

CONTACT US

Need more information? Would like to provide feedback? Interested in collaboration?
Ajanta Razine Tile WO
Ajanta Alduet Tile WO
Ajanta Dimezine22
Ajanta Fenostat
Ajanta Glyzeric Tile WO
Ajanta Kamagra Tile WO
Ajanta Nebiloc
Ajanta Neurogesic Tile WO
Ajanta Synactiv
Ajanta Warik2 Main W
Warik
Warik Saves
Ajanta Dimezine222
Dimezine
Stops Vertigo Spinning Out of Control
Ajanta Tri-Senza2
Tri-Senza
Helps Bring HbA1c Back to Target
Ajanta Alzor HCT Main W
Alzor HCT
Helping More Patients Achieve Target BP
Ajanta Nebiloc2
Nebiloc CCB
Ajanta Synactiv2
Synactiv
BIG on Effective.en
Ajanta Glyzeric Main W
Glyzeric
Two Great Performers
Ajanta Kamagra Main W
Kamagra
Kamagra Inspires Confidence
Ajanta Razine Main W
Razine
Take control of Angina
Ajanta Neurogesic Main W
Nurogesic B
Dual Acting Relief for Diabetic Neuropathy
Ajanta Glipten Main W
Glipten
Take Control of Type ll Diabetes
Ajanta Fenostat2
Fenostat
The Good, The Bad and the Ugly
Ajanta Maxivent2
Maxivent
Helps Patients with COPD Breathe Better
Ajanta Alzor HCT Main W
Alzor HCT
Helping More Patients Achieve Target BP
Ajanta Kamagra Main W
Kamagra
Kamagra Inspires Confidence
Ajanta Warik2 Main W
Warik
Warik Saves
Ajanta Rosugrel2
Rosugrel
Dual Vascular Protection
Ajanta Nebiloc2
Nebiloc CCB
Ajanta Rosucol2
Rosucol
Rosucol Delivers
Ajanta Neurogesic Main W
Nurogesic B
Dual Acting Relief for Diabetic Neuropathy
Ajanta Atenurix Main W
Atenurix
Best in Class Anti-hyperuricemic Agent
Ajanta Tamplus Main W
Tamplus
Optional BPH Symptom Relief. Optional Prevention of Progression of BPH
Ajanta Rosuprin2
Rosuprin
Dual Protection
Ajanta Glipten Main W
Glipten
Take Control of Type ll Diabetes
  • LATEST ARTICLES
07.22.2014
Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
Hyperuricemia is a frequent complication of chronic kidney disease (CKD). Febuxostat is a novel xanthine oxidase inhibitor that is metabolized...

Read more...

07.07.2014
Ajanta Pharma Philippines Inc introduces Glyzeric; the first fixed dose combination containing the gliclazide 80mg and metformin 500mg for the...

Read more...

06.18.2014
Tri-Senza, Fenostat and Dimezine, three new and first to market fixed dose combinations launched. Tri-Senza is a triple combination containing...

Read more...

05.08.2014
Fenostat, containing atorvastatin 10mg and fenofibrate 160mg, helps lower LDL cholesterol and triglycerides while increasing HDL cholesterol.

Read more...

05.05.2014
Dimezine (a fixed dose combination of dimenhydrinate 40mg and cinnarizine 20mg) is the first new treatment option for vertigo in...

Read more...

  • LATEST ARTICLES
07.22.2014
Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
Hyperuricemia is a frequent complication of chronic kidney disease (CKD). Febuxostat is a novel xanthine oxidase inhibitor that is metabolized...

Read more...

07.07.2014
Ajanta Pharma Philippines Inc introduces Glyzeric; the first fixed dose combination containing the gliclazide 80mg and metformin 500mg for the...

Read more...

06.18.2014
Tri-Senza, Fenostat and Dimezine, three new and first to market fixed dose combinations launched. Tri-Senza is a triple combination containing...

Read more...

05.08.2014
Fenostat, containing atorvastatin 10mg and fenofibrate 160mg, helps lower LDL cholesterol and triglycerides while increasing HDL cholesterol.

Read more...

05.05.2014
Dimezine (a fixed dose combination of dimenhydrinate 40mg and cinnarizine 20mg) is the first new treatment option for vertigo in...

Read more...

ABOUT US

A wholly owned subsidiary of a global pharmaceutical supplier

OUR PRODUCTS

First to market pharmaceutical compounds, unique therapeutically optimized combinations, value branded equivalents

CAREERS @ AJANTA

Looking for a challenging and rewarding career?

Apply here

PATIENT RESOURCES

Links to online educational materials